Asleep Spray (DSIP + Melatonin)
|Molar Mass||232.283 g/mol|
|Delta sleep-inducing peptide|
|Molar Mass||848.8 g/mol|
|IUPAC Name||DL-tryptophyl-DL-alanyl-glycyl-glycyl-DL-alpha-aspartyl-DL-alanyl-DL-seryl-glycyl-DL-glutamic acid|
DSIP + Melatonin is a research compound expressly formulated for scientific investigations and is strictly not intended for human consumption. This combination comprises Delta Sleep-Inducing Peptide (DSIP) and Melatonin, presenting an intriguing avenue for research into potential synergies and applications related to sleep and associated conditions.
The key characteristics of DSIP + Melatonin lie in the combination of DSIP, known for its role in sleep regulation, and Melatonin, a hormone associated with circadian rhythm and sleep-wake cycles. Researchers are exploring the unique qualities and potential synergies arising from this combination.
Scientists are actively exploring the research applications of DSIP + Melatonin, particularly in the realm of sleep regulation, insomnia, and related conditions. This combination presents an opportunity to delve into the potential interactions between DSIP and Melatonin in a controlled research environment.
DSIP + Melatonin Synergistic Potential
Preliminary studies suggest that the combination of DSIP and Melatonin may have synergistic effects on sleep-related processes. Ongoing research endeavors aim to uncover the mechanisms behind this synergy and its potential applications in the context of sleep regulation.
Delta Sleep-Inducing Peptide and Insomnia
DSIP, known for its involvement in sleep regulation, is being investigated for its potential role in addressing insomnia. Research studies are exploring whether DSIP, in combination with Melatonin, could offer insights into novel approaches for managing sleep disorders.
Melatonin on Fibromyalgia
Melatonin’s role in managing conditions such as fibromyalgia is under scrutiny in ongoing research. Investigations aim to understand the potential benefits of Melatonin, both independently and in combination with DSIP, in addressing symptoms associated with fibromyalgia.
DSIP + Melatonin, tailored for research purposes, is a subject of ongoing scientific inquiry. Researchers are actively exploring its potential synergies and applications in sleep regulation, insomnia, and conditions like fibromyalgia within controlled research settings.
- Dietrich Schneider-Helmert; Effects of Delta-Sleep-Inducing Peptide on 24-Hour Sleep-Wake Behaviour in Severe Chronic Insomnia. Eur Neurol 1 February 1987; 27 (2): 120–129. https://doi.org/10.1159/000116143. [Read More].
- Danilov, A., Kurganova, J. Melatonin in Chronic Pain Syndromes. Pain Ther 5, 1–17 (2016). https://doi.org/10.1007/s40122-016-0049-y. [Read More]